Effect of Non-Pharmacologic Vitamin D Status Correction on Circulating Bone Markers in Healthy Overweight and Obese Saudis
Abstract
:1. Introduction
2. Results
Baseline | 1 Year | P value | |
---|---|---|---|
N | 47 | 47 | |
Age (years) | 44.9 ± 9.7 | ||
Gender (M/F) | 21/26 | ||
BMI (kg/m2) | 31.8 ± 3.3 | 32.4 ± 3.1 | 0.13 |
Systolic BP (mmHg) | 116.5 ± 11.3 | 116.5 ± 17.2 | 0.94 |
Diastolic BP (mmHg) | 79.5 ± 8.2 | 76.0 ± 9.9 | 0.06 |
Hip circumference (cm) | 110.0 ± 9.2 | 112.8 ± 3.7 | 0.06 |
Waist circumference (cm) | 101.0 ± 10.5 | 98.6 ± 9.6 | 0.25 |
Glucose (mmol/L) | 5.4 ± 0.54 | 5.6 ± 0.60 | 0.09 |
Insulin (IU/mL) | 19.0 ± 3.5 | 24.1 ± 5.2 | 0.16 |
Triglycerides (mmol/L) | 1.4 ± 0.9 | 1.5 ± 0.84 | 0.57 |
Total Cholesterol (mmol/L) | 4.9 ± 1.1 | 4.8 ± 0.85 | 0.62 |
HDL-Cholesterol (mmol/L) | 0.91 ± 0.23 | 1.1 ± 0.39 | 0.005 |
LDL-Cholesterol (mmol/L) | 3.5 ± 0.90 | 3.4 ± 0.80 | 0.57 |
Vitamin D (nmol/L) | 30.3 ± 1.7 | 37.4 ± 1.5 | 0.001 |
PTH (pmol/L) | 0.78 ± 0.12 | 0.77 ± 0.14 | 0.71 |
Albumin (g/L) | 43.4 ± 4.6 | 41.7 ± 4.7 | 0.07 |
Calcium (mmol/L) | 2.4 ± 0.15 | 2.5 ± 0.32 | 0.04 |
Corrected calcium (mmol/L) | 2.7 ± 0.49 | 2.9 ± 0.56 | 0.06 |
Pi (mmol/L) | 1.0 ± 0.29 | 1.1 ± 0.16 | 0.04 |
Crosslaps(ng/mL) | 0.33 ± 0.16 | 0.23 ± 0.10 | <0.001 |
Osteocalcin (ng/mL) | 4.0 ± 1.2 | 5.1 ± 1.3 | <0.001 |
Osteopontin (ng/mL) | 9.2 ± 1.4 | 10.7 ± 1.1 | 0.23 |
Osteoprotegerin (pg/mL) | 404.4 ± 16.5 | 354.8 ± 12.5 | 0.05 |
Parameters | Osteocalcin | Crosslaps | ||
Baseline | 1 Year | Baseline | 1 Year | |
N | 47 | 47 | ||
BMI (kg/m2) | 0.27 | −0.59 * | −0.28 | −0.36 |
Systolic BP (mmHg) | −0.005 | −0.29 | 0.30 | 0.32 |
Diastolic BP (mmHg) | 0.20 | −0.43 * | 0.12 | 0.44 * |
Hips (cm) | 0.21 | −0.12 | −0.07 | −0.54 * |
Waist (cm) | 0.12 | −0.44 * | 0.13 | −0.11 |
Insulin (IU/mL) | 0.04 | −0.32 | 0.17 | −0.12 |
Calcium (mmol/L) | −0.40 * | −0.36 | −0.36 | −0.12 |
Corrected calcium (mmol/L) | −0.19 | −0.43 * | 0.32 | 0.16 |
Vitamin D (nmol/L) | −0.45 ** | −0.32 | 0.21 | 0.18 |
PTH (pmol/L) | −0.01 | 0.13 | −0.04 | −0.51 * |
Albumin (g/L) | 0.07 | 0.24 | 0.01 | 0.06 |
Glucose (mmol/L) | 0.003 | −0.03 | 0.02 | 0.11 |
Triglycerides (mmol/L) | 0.14 | −0.06 | −0.12 | 0.40 * |
Total Cholesterol (mmol/L) | −0.06 | −0.02 | −0.51 ** | 0.10 |
HDL-Cholesterol (mmol/L) | −0.25 | 0.05 | −0.15 | −0.37 |
Pi (mmol/L) | −0.20 | 0.02 | −0.39 | −0.14 |
Osteocalcin (ng/mL) | 0.42 * | −0.05 | ||
Osteopontin (ng/mL) | −0.20 | −0.09 | 0.26 | 0.15 |
Crosslaps (ng/mL) | 0.42 * | −0.05 | ||
Osteoprotegerin (pg/mL) | 0.27 | 0.08 | −0.16 | 0.29 |
3. Discussion
4. Experimental
4.1. Patients and Methods
4.2. Anthropometry and Blood Collection
4.3. Sunlight Exposure and Vitamin D Diet
4.4. Sample Analyses
4.5. Data Analysis
5. Conclusions
Acknowledgments
Conflicts of Interest
References
- Camacho, P.M.; Lopez, N.A. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis. Clin. Chem. Lab. Med. 2008, 46, 1345–1357. [Google Scholar]
- Vestergaard, P.; Stoen, O.G.; Swenson, J.E.; Mosekilde, L.; Heickendorff, L.; Frobert, O. Vitamin D status and bone and connective tissue turnover in brown bears (Ursus arctos) during hibernation and the active state. PLoS One 2011, 6, e21483. [Google Scholar]
- DeLuca, H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80, 1689S–1696S. [Google Scholar]
- Calvo, M.S.; Whiting, S.J.; Barton, C.N. Vitamin D fortification in the United States and Canada: Current status and data needs. Am. J. Clin. Nutr. 2004, 80, 1710S–1716S. [Google Scholar]
- Al-Turki, H.A.; Sadat-Ali, M.; Al-Elq, A.H.; Al-Mulhim, F.A.; Al-Ali, A.K. 25-Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Med. J. 2008, 29, 1765–1768. [Google Scholar]
- Sedrani, S.; Al-Arabi, K.; Abanmy, A.; Elidrissy, A. Vitamin D status of Saudis II. Effect of regional and environmental location. Saudi Med. J. 1992, 13, 206–213. [Google Scholar]
- O’Mahony, L.; Stepien, M.; Gibney, M.J.; Nugent, A.P.; Brennan, L. The potential role of vitamin D enhanced foods in improving vitamin D status. Nutrients 2011, 3, 1023–1041. [Google Scholar]
- Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80, 1678S–1688S. [Google Scholar]
- Holick, M.F. Vitamin D status: Measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73–78. [Google Scholar]
- Ardawi, M.S.; Sibiany, A.M.; Bakhsh, T.M.; Qari, M.H.; Maimani, A.A. High prevalence of vitamin D deficiency among healthy Saudi Arabian men: Relationship to bone mineral density, parathyroid hormone, bone turnover markers, and lifestyle factors. Osteoporos. Int. 2012, 23, 675–686. [Google Scholar]
- Bjarnason, N.H.; Christiansen, C. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 2000, 26, 561–569. [Google Scholar]
- Pi, Y.Z.; Wu, X.P.; Liu, S.P.; Luo, X.H.; Cao, X.Z.; Xie, H.; Liao, E.Y. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J. Bone Miner. Metab. 2006, 24, 380–385. [Google Scholar]
- Yamauchi, M.; Yamaguchi, T.; Nawata, K.; Takaoka, S.; Sugimoto, T. Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women. Clin. Nutr. 2010, 29, 761–765. [Google Scholar]
- Buransinsup, S. In vitro osteogenesis from human skin-derived precursor cells. Dev. Growth Differ. 2006, 48, 263–269. [Google Scholar]
- Suda, T.; Ueno, Y.; Fujii, K.; Shinki, T. Vitamin D and bone. J. Cell. Biochem. 2002, 88, 259–266. [Google Scholar]
- Pepe, J.; Romagnoli, E.; Nofroni, I.; Pacitti, M.T.; de Geronimo, S.; Letizia, C.; Tonnarini, G.; Scarpiello, A.; D’Erasmo, E.; Minisola, S. Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: A study in normal subjects. Osteoporos. Int. 2005, 16, 805–812. [Google Scholar]
- Mezquita-Raya, P.; Munoz-Torres, M.; Luna, J.D.; Luna, V.; Lopez-Rodriguez, F.; Torres-Vela, E.; Escobar-Jimenez, F. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J. Bone Miner. Res. 2001, 16, 1408–1415. [Google Scholar]
- Al-Saleh, Y.; Al-Daghri, N.M.; Alkharfy, K.M.; Al-Attas, O.S.; Alokail, M.S.; Al-Othman, A.; Sabico, S.; Chrousos, G.P. Normal circulating PTH in Saudi healthy individuals with hypovitaminosis D. Horm. Metab. Res. 2013, 45, 43–46. [Google Scholar]
- Hsu, H.; Lacey, D.L.; Dunstan, C.R.; Solovyev, I.; Colombero, A.; Timms, E.; Tan, H.L.; Elliott, G.; Kelley, M.J.; Sarosi, I.; et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 1999, 96, 3540–3545. [Google Scholar]
- Musso, G.; Paschetta, E.; Gambino, R.; Cassader, M.; Molinaro, F. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol. Med. 2013. [Google Scholar] [CrossRef]
- Zhou, J.; Zhang, Q.; Yuan, X.; Wang, J.; Li, C.; Hui, S.; Shen, Q.; Li, H. Association between metabolic syndrome and osteoporosis: A meta-analysis. Bone 2013, 57, 30–35. [Google Scholar]
- Wortsman, J.; Matsuoka, L.Y.; Chen, T.C.; Lu, Z.; Holick, M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000, 72, 690–693. [Google Scholar]
- Bao, Y.; Ma, X.; Yang, R.; Wang, F.; Hao, Y.; Dou, J.; He, H.; Jia, W. Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men. J. Clin. Endocrinol. Metab. 2013, 98, 345–351. [Google Scholar]
- Mohaved, A.; Larijani, B.; Nabipour, I.; Kalantarhormozi, M.; Asadipooya, K.; Vahdat, K.; Akbarzadeh, S.; Farrokhnia, M.; Assadi, M.; Amirinejad, R.; et al. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: The crosstalk between bone and energy metabolism. J. Bone Miner. Metab. 2012, 30, 683–691. [Google Scholar]
- Hannan, M.A.; Paul, M.; Amer, M.H.; Al-Watban, F.H. Study of ultraviolet radiation and genotoxic effects of natural sunlight in relation to skin cancer in Saudi Arabia. Cancer Res. 1984, 44, 2192–2197. [Google Scholar]
- Lai, J.K.; Lucas, R.M.; Banks, E.; Ponsonby, A.L. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern. Med. J. 2011, 42, 43–50. [Google Scholar]
- Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Statist. Soc. Ser. B (Methodological) 1995, 57, 289–300. [Google Scholar]
- Sample Availability: Subject samples are available from the authors.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Al-Daghri, N.M.; Alkharfy, K.M.; Al-Othman, A.; Yakout, S.M.; Al-Saleh, Y.; Fouda, M.; Sabico, S. Effect of Non-Pharmacologic Vitamin D Status Correction on Circulating Bone Markers in Healthy Overweight and Obese Saudis. Molecules 2013, 18, 10671-10680. https://doi.org/10.3390/molecules180910671
Al-Daghri NM, Alkharfy KM, Al-Othman A, Yakout SM, Al-Saleh Y, Fouda M, Sabico S. Effect of Non-Pharmacologic Vitamin D Status Correction on Circulating Bone Markers in Healthy Overweight and Obese Saudis. Molecules. 2013; 18(9):10671-10680. https://doi.org/10.3390/molecules180910671
Chicago/Turabian StyleAl-Daghri, Nasser M., Khalid M. Alkharfy, Abdulaziz Al-Othman, Sobhy M. Yakout, Yousef Al-Saleh, Mona Fouda, and Shaun Sabico. 2013. "Effect of Non-Pharmacologic Vitamin D Status Correction on Circulating Bone Markers in Healthy Overweight and Obese Saudis" Molecules 18, no. 9: 10671-10680. https://doi.org/10.3390/molecules180910671